Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jatin M. Patel is active.

Publication


Featured researches published by Jatin M. Patel.


Pharmaceutical Research | 2015

The Effect of Polymeric Excipients on the Physical Properties and Performance of Amorphous Dispersions: Part I, Free Volume and Glass Transition

Jinjiang Li; Junshu Zhao; Li Tao; Jennifer Wang; Vrushali Waknis; Duohai Pan; Mario Hubert; Krishnaswamy Srinivas Raghavan; Jatin M. Patel

PurposeTo investigate the structural effect of polymeric excipients on the behavior of free volume of drug-polymer dispersions in relation to glass transition.MethodsTwo drugs (indomethacin and ketoconazole) were selected to prepare amorphous dispersions with PVP, PVPVA, HPC, and HPMCAS through spray drying. The physical attributes of the dispersions were characterized using SEM and PXRD. The free volume (hole-size) of the dispersions along with drugs and polymers was measured using positron annihilation lifetime spectroscopy (PALS). Their glass transition temperatures (Tgs) were determined using DSC and DMA. FTIR spectra were recorded to identify hydrogen bonding in the dispersions.ResultsThe chain structural difference-flexible (PVP and PVPVA) vs. inflexible (HPC and HPMCAS)-significantly impacts the free volume and Tgs of the dispersions as well as their deviation from ideality. Relative to Tg, free volume seems to be a better measure of hydrogen bonding interaction for the dispersions of PVP, HPC, and HPMCAS. The free volume of polymers and their dispersions in general appears to be related to their conformations in solution.ConclusionsBoth the backbone chain rigidity of polymers as well as drug-polymer interaction can impact the free volume and glass transition behaviors of the dispersions.


Archive | 2008

Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate

Dilbir S. Bindra; Mandar V. Dali; Prakash Parab; Jatin M. Patel; Li Tao; Ravindra W. Tejwani; Nipa Vatsaraj; Yongemei Wu


Archive | 2008

Pharmaceutical formulations containing an sglt2 inhibitor

Dilbir S. Bindra; Mandar V. Dali; Prakash Parab; Jatin M. Patel; Li Tao; Ravindra W. Tejwani; Nipa Vatsaraj; Yongmei Wu


Archive | 1998

Salt form of nefazodone for use in extended release formulations

Hemant N. Joshi; Terry D. Wilson; Jatin M. Patel


Archive | 2010

Bilayer tablet formulations

Admassu Abebe; Kyle Martin; Jatin M. Patel; Divyakant Desai; Peter Timmins


Archive | 2010

Reduced mass metformin formulations

Jatin M. Patel; Admassu Abebe; Peter Timmins; Kyle Martin


Archive | 1995

Salts of nefazodone having improved dissolution rates

Hemant N. Joshi; Terry D. Wilson; Jatin M. Patel


Archive | 2010

Formulations de comprimé bicouche

Admassu Abebe; Kyle Martin; Jatin M. Patel; Divyakant Desai; Peter Timmins


Archive | 2010

Formulations de metformine a masse reduite

Jatin M. Patel; Admassu Abebe; Peter Timmins; Kyle Martin


Archive | 2008

Préparations pharmaceutiques contenant de l'hydrate de propylèneglycol de dapagliflozine

Dilbir S. Bindra; Mandar V. Dali; Prakash Parab; Jatin M. Patel; Li Tao; Ravindra W. Tejwani; Nipa Vatsaraj; Yongemei Wu

Collaboration


Dive into the Jatin M. Patel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Li Tao

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge